Atrium Therapeutics, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-31
Total Revenue19.6M859K
Cost of Goods Sold151K0
Gross Profit19.5M859K
R&D Expenses16.7M18.5M
Operating Expenses36.8M48.9M
Operating Income-17.3M-48.0M
Other Income / Gains647K0
Net Income-16.6M-48.1M
EPS (Diluted)-0.97-1.70
Reported CurrencyUSDUSD
Gross Profit Ratio0.9921.00
General And Administrative Expenses030.4M
Selling And Marketing Expenses00
Selling General And Administrative Expenses20.1M30.4M
Other Expenses00
Cost And Expenses36.9M48.9M
Interest Income00
Interest Expense00
Depreciation And Amortization151K122K
Ebitda-16.5M-47.9M
Ebitdaratio-0.839-55.778
Operating Income Ratio-0.88-55.92
Income Before Tax-16.6M-48.0M
Income Before Tax Ratio-0.847-55.92
Income Tax Expense034K
Net Income Ratio-0.847-55.959
Epsdiluted-0.97-1.70
Weighted Average Shs Out17.1M17.1M
Weighted Average Shs Out Dil17.1M17.1M